RISANKIZUMAB LEVELS ARE SIGNIFICANTLY CORRELATED AND PREDICTIVE OF BIOMARKER REMISSION IN CROHN'S DISEASE

Stéphane Paul  1     Louis Waeckel     Louise Merle     Anne-Emmanuelle Berger     Anne-Sophie Peaucelle     Mathilde Barrau     Xavier Roblin  2    
1 Hôpital Nord, Saint Etienne, France
2 University of St. Etienne, Saint Etienne, France

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing